Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05038696Phase 1Unknown
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
CARCAR T-Cell-Related Encephalopathy SyndromeLymphoblastic Leukemia+3 more
PrincipalinvestigatorStart date: 2021-04-28
NCT05043571Phase 1Recruiting
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
CARCAR T-Cell-Related Encephalopathy SyndromeLymphoblastic Leukemia+4 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dario Campana, M.D, PhD

National University of Singapore

Very Similar
2 trials

Shared therapeutic areas:

AutomobilesCAR T-Cell-Related Encephalopathy SyndromePrecursor Cell Lymphoblastic Leukemia-Lymphoma+4 more

Worked with same sponsors:

National University Hospital, Singapore
Collaborated on 2 trials
Similarity Score78%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Partow Kebriaei, MD

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05038696Phase 1PrincipalInvestigator

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

CARCAR T-Cell-Related Encephalopathy SyndromeLymphoblastic Leukemia+3 more
Unknown
NCT05043571Phase 1PrincipalInvestigator

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

CARCAR T-Cell-Related Encephalopathy SyndromeLymphoblastic Leukemia+4 more
Recruiting

All 2 trials loaded